Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Covington
Citi
McKinsey
Chinese Patent Office
Baxter
US Department of Justice
Harvard Business School
Teva

Generated: December 10, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GERMA-MEDICA MG

« Back to Dashboard

Clinical Trials for Germa-medica Mg

Trial ID Title Status Sponsor Phase Summary
NCT00270829 Renal Effects of Intrarenal Nesiritide Terminated University of Maryland Phase 4 The impact of nesiritide in CHF is unclear, but it is possible that systemic vasodilation leads to adverse consequences even if the direct renal effects are positive. Therefore, this study will look at the effects of direct intrarenal administration of nesiritide on GFR and RPF.
NCT01033630 Cardiovascular-Protective Effects of Herbal Medicine Danshen-Gegen Completed Chinese University of Hong Kong Phase 2 Atherosclerosis (in particular stroke and heart attack) is the most important health issue in modernized society and high blood pressure is an important predisposing factor. Hypertensive subjects with other chronic disease such as diabetes mellitus or impaired renal function are particularly vulnerable to these atherosclerotic complications in spite of standard antihypertensive therapies. Danshen and Gegen are commonly used in Chinese materia medica as treatment for cardiac symptoms and atherosclerosis-related disorders. The objective of this study is to test Danshen and Gegen as an cardiovascular-protective adjunctive regimen to prevent high-risk hypertensive cohort from primary atherosclerosis.
NCT01677247 Bioequivalence Study of 4 mg Glimepiride Tablet Completed Dexa Medica Group N/A This was a randomized, single blind, two-period, two sequence cross-over study under fasting condition to compare the bioavailability of two glimepiride 4 mg tablet formulations (test and reference formulations).
NCT01682577 Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition Completed Dexa Medica Group N/A The objective of this study was to find out whether the bioavailability of PT Dexa Medica's formulation of 4 mg perindopril tert-butylamine tablets was equivalent to that of the innovator's product (Prexum® 4 mg, Servier).
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Germa-medica Mg

Condition Name

Condition Name for Germa-medica Mg
Intervention Trials
Healthy 6
Small-cell Lung Cancer 2
Diabetes Mellitus 1
Hepatitis B, Chronic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Germa-medica Mg
Intervention Trials
Small Cell Lung Carcinoma 2
Lung Neoplasms 2
Nervous System Diseases 1
Diabetic Neuropathies 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Germa-medica Mg

Trials by Country

Trials by Country for Germa-medica Mg
Location Trials
Indonesia 7
China 3
Denmark 1
Hong Kong 1
South Africa 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Germa-medica Mg
Location Trials
Maryland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Germa-medica Mg

Clinical Trial Phase

Clinical Trial Phase for Germa-medica Mg
Clinical Trial Phase Trials
Phase 4 1
Phase 2/Phase 3 1
Phase 2 4
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Germa-medica Mg
Clinical Trial Phase Trials
Completed 9
Recruiting 5
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Germa-medica Mg

Sponsor Name

Sponsor Name for Germa-medica Mg
Sponsor Trials
Dexa Medica Group 7
Holger Rabitz og Hustru Doris Mary foedt Phillipps Mindelegat 1
Guizhou Medical University 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Germa-medica Mg
Sponsor Trials
Other 17
Industry 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Cipla
US Army
Argus Health
QuintilesIMS
Merck
Citi
Accenture
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.